BIO International Exhibitor Showcase

Sponsors face numerous challenges along the biologic drug development continuum, including increasing complexity, changing regulatory expectations, and getting therapies to market faster. Outsourcing allows sponsors to access established infrastructure, experienced teams, and quality frameworks that are aligned with regulatory standards. CDMOs can help them make informed decisions, avoid unnecessary risks, and maintain momentum as programs advance, from early development to scale-up, manufacture, and the supply chain.